Symbol: |
MYCN
|
Description: |
v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) [Source:HGNC Symbol;Acc:7559]
|
Location: |
Chr2:16080686-16087129[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:257
Gene |
Compound |
Gen_sig |
Exp_pattern |
MYCN |
1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride |
0.001 |
Down |
MYCN |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.001 |
Down |
MYCN |
ANTINEOPLASTIC-625543 |
0.031 |
Down |
MYCN |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.011 |
Up |
MYCN |
cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) |
0.035 |
Down |
MYCN |
Naphtho[2,3-d]thiazole-4,9-dione, 2-[(4-nitrophenyl) amino]- |
0.003 |
Down |
MYCN |
NSC 634398 |
0.01 |
Up |
MYCN |
NSC 637128 |
0.014 |
Down |
MYCN |
Dichlorobis[1-(4-nitrophenyl)-3-phenylpropane-1,3-dionato]-titanium(IV) |
0.016 |
Down |
MYCN |
(E)Methyl-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoate |
0.012 |
Down |
MYCN |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.015 |
Down |
MYCN |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride |
0.022 |
Down |
MYCN |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3-methoxy- phenyl)methylene]-, hydrochloride |
0.001 |
Down |
MYCN |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride |
0.036 |
Down |
MYCN |
Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride |
0.023 |
Down |
Expression pattern: Sensitivity / Resistance
Total:18 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:13
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:57
Total:4 Current:1
[First] [Prev]  Next Last 
|